Net kâr · 2025 mali yılı
| 1 | Johnson & JohnsonJNJ | $26,8B |
|---|---|---|
| 2 | Eli LillyLLY | $20,6B |
| 3 | MerckMRK | $18,3B |
| 4 | Novo Nordisk A SNVO | $15,5B |
| 5 | UnitedHealth GroupUNH | $12,1B |
| 6 | AstraZenecaAZN | $10,2B |
| 7 | Gilead SciencesGILD | $8,5B |
| 8 | PfizerPFE | $7,8B |
| 9 | AmgenAMGN | $7,7B |
| 10 | GSKGSK | $7,5B |